Ownership and insider activity for NeuroOne Medical Technologies Corporation (NMTC): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
NeuroOne Medical Technologies Corporation functions as a specialized medical technology enterprise. Its core mission involves the invention and market deployment of sophisticated thin-film electrode systems.
Price
| Price | $1.41 |
| Market Cap | $12M |
| Exchange | NASDAQ |
| Country | US |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-08-27 | Wambeke David J. | P-Purchase | 33,333 | $67K |
| 2026-08-28 | Wambeke David J. | A-Award | 35,000 | $62K |
| 2026-08-28 | Johns Emily J. | A-Award | 12,500 | $22K |
| 2026-08-28 | Volker Christopher | A-Award | 35,000 | $62K |
| 2026-08-28 | Christianson Mark | A-Award | 12,500 | $22K |
| 2026-08-28 | Mertens Steve | A-Award | 15,000 | $27K |
| 2026-08-28 | Rosa David A | A-Award | 68,000 | $120K |
| 2026-07-10 | Pratt Brian | |||
| 2026-06-30 | Christianson Mark | S-Sale | 10,000 | $32K |
| 2026-04-03 | Mills Jason Richard | A-Award | 41,929 |
Balance Sheet (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $522217 | $26467 | $13260 | $260749 | $4.0M | $6.9M | $8.2M | $5.3M | $1.5M | $6.6M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 | 0 | $3.0M | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | $48336 | $33237 | 0 | $176636 | $1.3M |
| Inventory | 0 | 0 | 0 | 0 | 0 | $98287 | $704538 | $1.7M | $2.6M | $2.2M |
| Total Current Assets | $576040 | $33613 | $18638 | $301751 | $4.2M | $7.3M | $12.2M | $7.3M | $4.6M | $10.2M |
| Property, Plant & Equipment | 0 | 0 | 0 | $52026 | $448242 | $512277 | $534954 | $694812 | $671753 | $514417 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | $180890 | $216372 | $200081 | $178838 | $156523 | $134207 | $111892 | $89577 | $67262 | $44946 |
| Total Assets | $756930 | $249985 | $218719 | $532615 | $4.8M | $7.9M | $12.8M | $8.1M | $5.4M | $10.8M |
| Accounts Payable | $22362 | 0 | $221235 | $1.2M | $762538 | $528829 | $927662 | $685104 | $1.0M | $1.0M |
| Short-term Debt | $275197 | $2.4M | $1.7M | 0 | $1.0M | 0 | 0 | 0 | 0 | 0 |
| Total Current Liabilities | $677190 | $3.9M | $3.8M | $1.8M | $2.4M | $1.2M | $3.1M | $1.8M | $2.2M | $2.3M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | $1.0M | $5.3M | $4.6M | $1.8M | $2.7M | $1.4M | $3.2M | $1.8M | $4.5M | $3.7M |
| Retained Earnings | -$266370 | -$5.3M | -$10.5M | -$17.2M | -$30.9M | -$40.8M | -$50.8M | -$62.7M | -$75.0M | -$78.6M |
| Total Equity | -$266220 | -$5.0M | -$4.4M | -$1.2M | $2.1M | $6.6M | $9.6M | $6.2M | $822013 | $7.1M |
| Total Debt | $275197 | $2.4M | $1.7M | 0 | $1.3M | $315673 | $202895 | $184400 | $260160 | $266806 |
| Net Debt | -$247020 | $2.4M | $1.7M | -$260749 | -$2.7M | -$6.6M | -$10.9M | -$5.1M | -$1.2M | -$6.3M |
| Working Capital | -$101150 | -$3.9M | -$3.8M | -$1.5M | $1.8M | $6.1M | $9.1M | $5.5M | $2.4M | $7.9M |
Financial Health
| Debt / Equity | 0.02 |
| Current Ratio | 2.84 |
Profitability
| Return on Equity | -126.45% |
| Return on Invested Capital | -183.45% |
| Return on Assets | -115.57% |
| Gross Margin | 55.67% |
| Operating Margin | -76.05% |
| Net Margin | -71.51% |
Related companies: ATHE · BDMD · CTSO · ECOR · HYPD · MYO · RBOT
Explore sector: Healthcare · Medical - Devices
More sections of NMTC: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks